Success of ceftazidime–avibactam and aztreonam in combination for a refractory biliary infection with recurrent bacteraemia due to blaIMP-4 carbapenemase-producing Enterobacter hormaechei subsp. oharae

BACKGROUND: Infections due to metallo-beta-lactamase (MBL)-producing organisms are becoming a significant problem, and antibiotic treatment options are limited. Aztreonam inhibits MBLs, and its use in combination with ceftazidime–avibactam (CAZ–AVI–AZT) to inhibit other beta-lactamases shows promise...

Descripción completa

Detalles Bibliográficos
Autores principales: McKew, Genevieve, Merlino, John, Beukers, Alicia, van Hal, Sebastian, Gottlieb, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Microbiology Society 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650849/
https://www.ncbi.nlm.nih.gov/pubmed/34888479
http://dx.doi.org/10.1099/acmi.0.000248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650849/
https://www.ncbi.nlm.nih.gov/pubmed/34888479
http://dx.doi.org/10.1099/acmi.0.000248

Ejemplares similares